Cancer Research AACR Membership  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 3171-3174, July 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kreuzer, K.-A.
Right arrow Articles by Schmidt, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kreuzer, K.-A.
Right arrow Articles by Schmidt, C. A.
[Cancer Research 59, 3171-3174, July 1, 1999]
© 1999 American Association for Cancer Research


Molecular Biology and Genetics

LightCycler Technology for the Quantitation of bcr/abl Fusion Transcripts

Karl-Anton Kreuzer, Ulrich Lass, Alexander Bohn, Olfert Landt and Christian Andreas Schmidt1

Abteilung für Innere Medizin und Poliklinik m.S. Hä matologie und Onkologie, Campus Virchow-Klinikum, Medizinische Fakultät Charité der Humboldt-Universität zu Berlin, 13353 Berlin [K-A. K., U. L., A. B., C. A. S.]; and TIB Molbiol Inc., 10829 Berlin [O. L.], Germany

Quantifying bcr/abl fusion transcripts in chronic myelogenous leukemia is thought to serve as a powerful parameter for monitoring the kinetic nature of this clonal disease in vivo and in vitro. Recently, we demonstrated the technical advantages as well as the clinical relevance of quantitating bcr/abl fusion mRNA using the 5-nuclease assay and a real-time fluorescence reverse transcriptase-PCR (RT-PCR) detection system (ABI PRISM 7700 SDS). Meanwhile, another technique was introduced (LightCycler technology) that may be used for the same purpose. To investigate whether this method may be an appropriate alternative to the described procedure, we have established bcr/abl LightCycler RT-PCR for major and minor bcr/abl fusion transcripts. We found that, with only minor modifications, TaqMan RT-PCR and fluorescent probe design can be used to obtain comparable results in the LightCycler system. The developed method could quantitate as little as 10 bcr/abl copies per 100 ng cDNA and was as safe and reproducible as the previously described technique. Because reaction efficiency was identical within different bcr/abl major fusions, one single RT-PCR could be established that simultaneously detects b2a3, b2a2, b3a2, and b3a3 fusion RNA with equal specificity and sensitivity. Compared to results generated by the ABI PRISM 7700 SDS, absolute amounts of bcr/abl did not differ significantly, and there was a linear correlation between the respective values. We conclude that TaqMan chemistry can be used in the LightCycler and that both real-time fluorescence PCR detection systems equally fulfill the criteria for the safe and reliable quantitation of bcr/abl fusion RNA in clinical samples. This may be of help for further standardization of quantitative bcr/abl RT-PCR, which, again, is necessary for the comparison of results generated by different investigators.




This article has been cited by other articles:


Home page
J. Mol. Diagn.Home page
E. Lyon and C. T. Wittwer
LightCycler Technology in Molecular Diagnostics
J. Mol. Diagn., March 1, 2009; 11(2): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
M. Schaich, L. Kestel, M. Pfirrmann, K. Robel, T. Illmer, M. Kramer, C. Dill, G. Ehninger, G. Schackert, and D. Krex
A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients
Ann. Onc., January 1, 2009; 20(1): 175 - 181.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
M. Baccarani, F. Pane, and G. Saglio
Monitoring treatment of chronic myeloid leukemia
Haematologica, February 1, 2008; 93(2): 161 - 169.
[Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
T. Zhang, S. Grenier, B. Nwachukwu, C. Wei, J. H. Lipton, S. Kamel-Reid, and the Association for Molecular Pathology Hematopath
Inter-Laboratory Comparison of Chronic Myeloid Leukemia Minimal Residual Disease Monitoring: Summary and Recommendations
J. Mol. Diagn., September 1, 2007; 9(4): 421 - 430.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. J. Yun, L. E. Heisler, I. I. L. Hwang, O. Wilkins, S. K. Lau, M. Hyrcza, B. Jayabalasingham, J. Jin, J. McLaurin, M.-S. Tsao, et al.
Genomic DNA functions as a universal external standard in quantitative real-time PCR
Nucleic Acids Res., July 13, 2006; 34(12): e85 - e85.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
M. I. Gutierrez, G. Timson, A. K. Siraj, R. Bu, S. Barbhaya, S. Banavali, and K. Bhatia
Single Monochrome Real-Time RT-PCR Assay for Identification, Quantification, and Breakpoint Cluster Region Determination of t(9;22) Transcripts
J. Mol. Diagn., February 1, 2005; 7(1): 40 - 47.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. Bolufer, D. Colomer, M. T. Gomez, J. Martinez, S. M. Gonzalez, M. Gonzalez, J. Nomdedeu, B. Bellosillo, E. Barragan, F. Lo-Coco, et al.
Quantitative Assessment of PML-RARa and BCR-ABL by Two Real-Time PCR Instruments: Multiinstitutional Laboratory Trial
Clin. Chem., June 1, 2004; 50(6): 1088 - 1092.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
J. P. Frade, D. W. Warnock, and B. A. Arthington-Skaggs
Rapid Quantification of Drug Resistance Gene Expression in Candida albicans by Reverse Transcriptase LightCycler PCR and Fluorescent Probe Hybridization
J. Clin. Microbiol., May 1, 2004; 42(5): 2085 - 2093.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Z. Shi, J. M. Morrissey, and J. D. Rowley
Screening and Quantification of Multiple Chromosome Translocations in Human Leukemia
Clin. Chem., July 1, 2003; 49(7): 1066 - 1073.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
A. L. Nashed, K. W. Rao, and M. L. Gulley
Clinical Applications of BCR-ABL Molecular Testing in Acute Leukemia
J. Mol. Diagn., May 1, 2003; 5(2): 63 - 72.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
Q. He, J.-P. Wang, M. Osato, and L. B. Lachman
Real-Time Quantitative PCR for Detection of Helicobacter pylori
J. Clin. Microbiol., October 1, 2002; 40(10): 3720 - 3728.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
A. Bagg
Chronic Myeloid Leukemia: A Minimalistic View of Post-Therapeutic Monitoring
J. Mol. Diagn., February 1, 2002; 4(1): 1 - 10.
[Full Text] [PDF]


Home page
Hum ReprodHome page
M. Schrader, M. Muller, W. Schulze, R. Heicappell, H. Krause, B. Straub, and K. Miller
Quantification of the expression level of the gene encoding the catalytic subunit of telomerase in testicular tissue specimens predicts successful sperm recovery
Hum. Reprod., January 1, 2002; 17(1): 150 - 156.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
I. Hein, A. Lehner, P. Rieck, K. Klein, E. Brandl, and M. Wagner
Comparison of Different Approaches To Quantify Staphylococcus aureus Cells by Real-Time Quantitative PCR and Application of This Technique for Examination of Cheese
Appl. Envir. Microbiol., July 1, 2001; 67(7): 3122 - 3126.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. A. Foy and H. C. Parkes
Emerging Homogeneous DNA-based Technologies in the Clinical Laboratory
Clin. Chem., June 1, 2001; 47(6): 990 - 1000.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Seeger, K.-A. Kreuzer, U. Lass, T. Taube, D. Buchwald, C. Eckert, G. Körner, C.-A Schmidt, and G. Henze
Molecular Quantification of Response to Therapy and Remission Status in TEL-AML1-Positive Childhood ALL by Real-Time Reverse Transcription Polymerase Chain Reaction
Cancer Res., March 1, 2001; 61(6): 2517 - 2522.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
J. Wilhelm, M. Hahn, and A. Pingoud
Influence of DNA Target Melting Behavior on Real-Time PCR Quantification
Clin. Chem., November 1, 2000; 46(11): 1738 - 1743.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Usui, S. Amano, T. Oshika, K. Suzuki, K. Miyata, M. Araie, P. Heldin, and H. Yamashita
Expression Regulation of Hyaluronan Synthase in Corneal Endothelial Cells
Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3261 - 3267.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
C. Ruiz-Ponte, L. Loidi, A. Vega, A. Carracedo, and F. Barros
Rapid Real-Time Fluorescent PCR Gene Dosage Test for the Diagnosis of DNA Duplications and Deletions
Clin. Chem., October 1, 2000; 46(10): 1574 - 1582.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Kang, H. Xu, X. Duan, J.-J. Liu, Z. He, F. Yu, S. Zhou, X.-Q. Meng, M. Cao, and G. C. Kennedy
PCD1, a Novel Gene Containing PDZ and LIM Domains, Is Overexpressed in Several Human Cancers
Cancer Res., September 1, 2000; 60(18): 5296 - 5302.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
G. Barbany, A. Hagberg, U. Olsson-Stromberg, B. Simonsson, A.-C. Syvanen, and U. Landegren
Manifold-assisted Reverse Transcription-PCR with Real-Time Detection for Measurement of the BCR-ABL Fusion Transcript in Chronic Myeloid Leukemia Patients
Clin. Chem., July 1, 2000; 46(7): 913 - 920.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Nakao, J. W. G. Janssen, T. Flohr, and C. R. Bartram
Rapid and Reliable Quantification of Minimal Residual Disease in Acute Lymphoblastic Leukemia Using Rearranged Immunoglobulin and T-Cell Receptor Loci by LightCycler Technology
Cancer Res., June 1, 2000; 60(12): 3281 - 3289.
[Abstract] [Full Text]


Home page
Nucleic Acids ResHome page
J. Nurmi, A. Ylikoski, T. Soukka, M. Karp, and T. Lovgren
A new label technology for the detection of specific polymerase chain reaction products in a closed tube
Nucleic Acids Res., April 15, 2000; 28(8): e28 - e.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.